#AMMF will be hosting the third session in our patient and carer webinar series: Understanding the role of stents in the management of #cholangiocarcinoma Date: 24th September2025 Time: 6:00pm–7:30pm BST Location: https://t.co/8a6UmXQ9SK #bileductcancer #stents #CCA #webinar

🔬Spotlight on research🔬🔬 Head over to #AMMF’s Facebook page to hear more information from Dr Ed Jarman. Dr Jarman will be sharing his insights on his #AMMF funded #research. https://t.co/FW9VbFRgGf #CCA #cholangiocarcinoma #bileductcancer

#AMMF will be hosting the third session in our patient and carer webinar series: Understanding the role of stents in the management of #cholangiocarcinoma Date: 24th September2025 Time: 6:00pm–7:30pm BST Location: https://t.co/8a6UmXQ9SK #bileductcancer #stents #CCA #webinar

🔬Spotlight on research🔬🔬 Head over to #AMMF’s social media platforms to hear more information from our very own Head of Policy and Research, Paul Howard. Paul will be sharing his insights on AMMF funded #research. https://t.co/29cDvI8geG #CCA #cholangiocarcinoma

#AMMF will be joined by Dr Christopher Wadsworth, Professor Sheela Jayaramen & CCA patient advocates in the upcoming webinar on the role of stents. Date: 24th September 2025 Time: 6:00pm–7:30pm BST Location: https://t.co/8a6UmXQ9SK #bileductcancer #stents #CCA #cholangiocarcinoma

The next @ccaukgroup meeting will be held in December 2025 in Nottingham. The focus of the meeting with be the fundamental science underlying #cholangiocarcinoma and is aimed at researchers and clinicians. Further details will be shared in due course. #AMMF #bileductcancer #CCA

#AMMF will be hosting the third session in our patient and carer webinar series: Understanding the role of stents in the management of #cholangiocarcinoma. Date: 24th September 2025 Time: 6:00pm–7:30pm BST Location: https://t.co/8a6UmXQ9SK #bileductcancer #stents #CCA #webinar

On 27 August 2025 #AMMF united with 60 other cancer charities outside the Houses of Parliament to urge the UK Government to deliver a #NationalCancerPlan that is ambitious and fully funded. #OneCancerVoice #Cholangiocarcinoma #BileDuctCancer #CCA #RethinkLiverCancer

As part of @Cancer52org, we know improved diagnosis, treatment and support for those affected is crucial. The National Cancer Plan must reflect this with focused and targeted action. #OneCancerVoice

#charityAMMF's European Website AMMF is committed to supporting those in the UK and European patients and carers living with #cholangiocarcinoma. AMMF's European website offers trusted information and support in 8 different languages and more on the way! https://t.co/FccOVQp0N6

🔬Spotlight on Research🔬 Throughout September #AMMF will be showcasing both previously funded and newly funded research projects, this will highlight the importance even small grants can be in kickstarting this critical research. #bileductcancer #CCA #cholangiocarcinoma

🟣SAVE THE DATE🟣 #AMMF is pleased to announce the save the date details of our annual European #Cholangiocarcinoma Conference May 2026. 📅: 13-15 May 2026 📍: Radisson Blu, Stanstead, UK Further information regarding registration will be provided soon. #bileductcancer #CCA

Did you know that #AMMF are on BlueSky? AMMF are across all social media platforms, making it easier than ever to keep up to date with all the latest news, information on trials, #cholangiocarcinoma treatments and upcoming events! Search @charityammf and hit the follow button!

This month, the UK Government launched its #10YearHealthPlan for England. To read about what this could mean for #cholangiocarcinoma patients, visit the following link: https://t.co/3kuX5SGQwK #AMMF

THANK YOU to everyone who completed #AMMF's recent surveys. We received 80 responses (34 from people with a #BiliaryTractCancer and 36 from their partners/family/caregivers). Your contributions will help our efforts to get new treatments approved for use in the NHS.

#AMMF recently hosted its annual #cholangiocarcinoma conference. We are delighted to share highlights from the 3 days. Hear from the attendees including specialists, patients and our sponsors explain what attending meant to them. https://t.co/KFKPxNnr17

The Rare Cancers Bill has passed! I am proud to have supported this bill all the way through parliament from the beginning. The bill will improve rare cancer treatment by enhancing data-sharing and requiring public reporting on access to life-saving orphan drugs—offering new

The #RareCancersBill is moving through UK Parliament—offering hope to those facing rare & less survivable cancers. It tackles: Delayed diagnoses Limited treatments Lower survival rates Write to your MP. Because rare shouldn’t mean forgotten. #CancerAwareness #HealthEquity

Write to your MP and support the #RareCancersBill. Call for: More research Rare cancer champions in all UK nations Better incentives for orphan drugs Let’s push for better care, faster diagnoses & more hope. #CancerAwareness #HealthEquity #cholangiocarcinoma #CCA #AMMF

Dr Chris Wadsworth explained the difference between ERCP and PTC, and how both can play their roles when stenting is being considered for a #cholangiocarcinoma patient during #AMMF's conference in May Watch back the presentation at https://t.co/sQMKQOpJFZ #bileductcancer